{"url_path":"/sec/galt/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1133416/0001140361-26-021495-index.html","accession_number":"0001140361-26-021495","cik":"0001133416","ticker":"GALT","issuer_name":"GALECTIN THERAPEUTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1133416/0001140361-26-021495-index.html","primary_entity_key":"0001133416","primary_entity_name":"GALECTIN THERAPEUTICS INC"},"word_count":55,"has_tables":true,"body_markdown":"Item 1A.\n\nRisk Factors\n\n \n\nThe information set forth in this report should be read in conjunction with the risk factors set forth in Item 1A, “Risk Factors,” of Part I of our Annual Report on Form 10-K for the year ended December 31, 2025, which could materially impact our business, financial condition or future results."}